» Articles » PMID: 22948816

Extracellular ATP Mediates Mast Cell-dependent Intestinal Inflammation Through P2X7 Purinoceptors

Overview
Journal Nat Commun
Specialty Biology
Date 2012 Sep 6
PMID 22948816
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Mast cells are known effector cells in allergic and inflammatory diseases, but their precise roles in intestinal inflammation remain unknown. Here we show that activation of mast cells in intestinal inflammation is mediated by ATP-reactive P2X7 purinoceptors. We find an increase in the numbers of mast cells expressing P2X7 purinoceptors in the colons of mice with colitis and of patients with Crohn's disease. Treatment of mice with a P2X7 purinoceptor-specific antibody inhibits mast cell activation and subsequent intestinal inflammation. Similarly, intestinal inflammation is ameliorated in mast cell-deficient Kit(W-sh/W-sh) mice, and reconstitution with wild-type, but not P2x7(-/-) mast cells results in susceptibility to inflammation. ATP-P2X7 purinoceptor-mediated activation of mast cells not only induces inflammatory cytokines, but also chemokines and leukotrienes, to recruit neutrophils and subsequently exacerbate intestinal inflammation. These findings reveal the role of P2X7 purinoceptor-mediated mast cell activation in both the initiation and exacerbation of intestinal inflammation.

Citing Articles

Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases.

Molfetta R, Carnevale A, Marangio C, Putro E, Paolini R Biomedicines. 2025; 13(2).

PMID: 40002733 PMC: 11853218. DOI: 10.3390/biomedicines13020320.


Rutin: a pain-relieving flavonoid.

Forouzanfar F, Sahranavard T, Tsatsakis A, Iranshahi M, Rezaee R Inflammopharmacology. 2025; .

PMID: 39961908 DOI: 10.1007/s10787-025-01671-8.


Extracellular ATP Contributes to Barrier Function and Inflammation in Atopic Dermatitis: Potential for Topical Treatment of Atopic Dermatitis by Targeting Extracellular ATP.

Yamamura K, Ohno F, Yotsumoto S, Sato Y, Kimura N, Nishio K Int J Mol Sci. 2024; 25(22).

PMID: 39596359 PMC: 11595171. DOI: 10.3390/ijms252212294.


QcrC is a potential target for antibody therapy and vaccination to control infection by suppressing its energy metabolism.

Hosomi K, Hatanaka N, Hinenoya A, Adachi J, Tojima Y, Furuta M Front Microbiol. 2024; 15:1415893.

PMID: 39015740 PMC: 11250076. DOI: 10.3389/fmicb.2024.1415893.


The omega-3 postbiotic -10--15-octadecadienoic acid attenuates contact hypersensitivity in mice through downregulation of vascular endothelial growth factor A.

Saika A, Nagatake T, Kishino S, Kitamura N, Honda T, Hosomi K Front Cell Infect Microbiol. 2024; 14:1355679.

PMID: 38841110 PMC: 11151274. DOI: 10.3389/fcimb.2024.1355679.


References
1.
Fiorucci S, Mencarelli A, Palazzetti B, Sprague A, Distrutti E, Morelli A . Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis. Immunity. 2002; 17(6):769-80. DOI: 10.1016/s1074-7613(02)00476-4. View

2.
He S . Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol. 2004; 10(3):309-18. PMC: 4724914. DOI: 10.3748/wjg.v10.i3.309. View

3.
Wareham K, Vial C, Wykes R, Bradding P, Seward E . Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol. 2009; 157(7):1215-24. PMC: 2743840. DOI: 10.1111/j.1476-5381.2009.00287.x. View

4.
Wirtz S, Neufert C, Weigmann B, Neurath M . Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007; 2(3):541-6. DOI: 10.1038/nprot.2007.41. View

5.
Nigrovic P, Gray D, Jones T, Hallgren J, Kuo F, Chaletzky B . Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol. 2008; 173(6):1693-701. PMC: 2626381. DOI: 10.2353/ajpath.2008.080407. View